ProVen Pharmaceuticals - Crunchbase Company Profile & Funding

Overview

ProVen Pharmaceuticals

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About ProVen Pharmaceuticals

CB Rank

1036160

ProVen Pharma is specializes in service provider to the healthcare and life science industries.

Acquired by

Prothya Biosolutions Netherlands

Founded

obfuscation

Private

Plymouth Meeting, Pennsylvania, United States

11-50

www.provenpharma.com/

Biotechnology

Health Care

Life Science

Pharmaceutical

Details

Sub-Organization of

Prothya Biosolutions Netherlands

Operating Status

Active

Company Type

For Profit

Phone Number

855-678-7768

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Specialty Pharmaceutical Distribution

Provides distribution of specialty pharmaceutical products requiring expert handling and compliance.

Comparator Sourcing for Clinical Trials

Sources comparator pharmaceutical products needed for clinical trial studies.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

ProVen Pharmaceuticals

was acquired by

Prothya Biosolutions Netherlands

obfuscation

Transaction Name

ProVen Pharmaceuticals acquired by Prothya Biosolutions Netherlands

Acquired by

Prothya Biosolutions Netherlands

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Contacts

News

Technology

View Tech Report

Monthly Web Visits

IT Spend

$1.1M

This year,

ProVen Pharmaceuticals

is projected to spend

$1.1M

on IT, according to Aberdeen.

Interest Signals

Topic	Surge Score
Conflict Resolution	71
Employee Attendance Software	71
Employee Discounts	71

Active Website Tech Count

ProVen Pharmaceuticals

is actively using

technologies for its website, according to BuiltWith. These include

Viewport Meta

IPhone / Mobile Compatible

, and

SSL by Default

Lists Featuring This Company

Biotechnology Acquired Companies With More Than 10 Employees

2,097 Number of Organizations • $189.4B Total Funding Amount • 6,147 Number of Investors

United States Pharmaceutical Companies (Top 10K)

9,829 Number of Organizations • $473.3B Total Funding Amount • 9,791 Number of Investors

Life Science Companies (Top 10K)

9,919 Number of Organizations • $267.6B Total Funding Amount • 15,351 Number of Investors

United States Pharmaceutical Acquired Companies

923 Number of Organizations • $81.9B Total Funding Amount • 1,647 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

ProVen Pharmaceuticals

's headquarters?

ProVen Pharmaceuticals

is located in

Plymouth Meeting, Pennsylvania, United States

Who are

ProVen Pharmaceuticals

's competitors? Alternatives and possible competitors to

ProVen Pharmaceuticals

may include

IQVIA

Cencora

, and

Syneos Health